GA

Gudya Aftab Shaikh

Active Director Director DIN 11497745
DIN 11497745 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Gudya Aftab Shaikh

Data last updated:

Gudya Aftab Shaikh is a Director at Okaz Bio-Tech Private Limited (since 2025). The company operates in Pharma. Okaz Bio-Tech Private Limited reported revenue of ₹1.15 Cr (FY 2025).

DIN 11497745
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2025
Largest company Okaz Bio-Tech Private Limited · ₹1.15 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Okaz Bio-Tech Private Limited U24230MH1999PTC121724
Director26 Sep 2025₹1.15 Cr (FY 2025)Active

Board colleagues of Gudya Aftab Shaikh

NameDINCompanyDesignation
Aftab Ahmed Riyaz Ahmed Shaikh03064777Okaz Bio-Tech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Okaz Bio-Tech Private Limited
Premium access

Shareholding and investment profile for Gudya Aftab Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gudya Aftab Shaikh

Gudya Aftab Shaikh currently holds 1 directorship: Okaz Bio-Tech Private Limited (Director, since 26 Sep 2025, revenue ₹1.15 Cr (FY 2025)).

Gudya Aftab Shaikh was first appointed on 26 Sep 2025 as Director at Okaz Bio-Tech Private Limited.

The current boards of Gudya Aftab Shaikh's companies include Aftab Ahmed Riyaz Ahmed Shaikh (Okaz Bio-Tech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available